{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T12:39:36Z","timestamp":1793882376615,"version":"4.7.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100022963","name":"Key Research and Development Program of Zhejiang Province","doi-asserted-by":"publisher","award":["2025C02070"],"award-info":[{"award-number":["2025C02070"]}],"id":[{"id":"10.13039\/100022963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQ21H030006"],"award-info":[{"award-number":["LQ21H030006"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQ22H160031"],"award-info":[{"award-number":["LQ22H160031"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370648"],"award-info":[{"award-number":["82370648"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070652"],"award-info":[{"award-number":["82070652"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jare.2025.02.016","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T19:22:09Z","timestamp":1739906529000},"page":"497-515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Comprehensive multi-omics analyses expose a precision therapy strategy that targets replication stress in hepatocellular carcinoma using WEE1 inhibition"],"prefix":"10.1016","volume":"78","author":[{"given":"Xing","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinuo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiongzi","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfeng","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijiang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zequn","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suchen","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haojiang","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqiao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zefeng","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiufang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shusen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penghong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jare.2025.02.016_b0005","first-page":"209","article-title":"Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jare.2025.02.016_b0010","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"Management of hepatocellular carcinoma","volume":"69","author":"Easl clinical practice guidelines","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jare.2025.02.016_b0015","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2015.05.061","article-title":"Genetic landscape and biomarkers of hepatocellular carcinoma","volume":"149","author":"Zucman-Rossi","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jare.2025.02.016_b0020","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/cac2.12115","article-title":"Molecular subtyping of hepatocellular carcinoma: A step toward precision medicine","volume":"40","author":"Wu","year":"2020","journal-title":"Cancer Commun (Lond)"},{"key":"10.1016\/j.jare.2025.02.016_b0025","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.cell.2019.10.038","article-title":"Integrated proteogenomic characterization of hbv-related hepatocellular carcinoma","volume":"179","author":"Gao","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.jare.2025.02.016_b0030","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1016\/j.molcel.2022.05.004","article-title":"Hallmarks of DNA replication stress","volume":"82","author":"Saxena","year":"2022","journal-title":"Mol Cell"},{"key":"10.1016\/j.jare.2025.02.016_b0035","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/nrc3916","article-title":"Replication stress and cancer","volume":"15","author":"Gaillard","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jare.2025.02.016_b0040","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41573-022-00558-5","article-title":"Targeting replication stress in cancer therapy","volume":"22","author":"da Costa","year":"2023","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jare.2025.02.016_b0045","doi-asserted-by":"crossref","DOI":"10.1038\/s41568-022-00518-6","article-title":"Leveraging the replication stress response to optimize cancer therapy","volume":"23","author":"Cybulla","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jare.2025.02.016_b0050","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1200\/JCO.21.00608","article-title":"Hepatic arterial infusion of oxaliplatin, fluorouracil, and leucovorin versus transarterial chemoembolization for large hepatocellular carcinoma: A randomized phase iii trial","volume":"40","author":"Li","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jare.2025.02.016_b0055","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1200\/JCO.2012.44.5643","article-title":"Randomized, multicenter, open-label study of oxaliplatin plus fluorouracil\/leucovorin versus doxorubicin as palliative chemotherapy in patients with advanced hepatocellular carcinoma from asia","volume":"31","author":"Qin","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jare.2025.02.016_b0060","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1002\/hep.32079","article-title":"Lsd1-demethylated linc01134 confers oxaliplatin resistance through sp1-induced p62 transcription in hcc","volume":"74","author":"Ma","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jare.2025.02.016_b0065","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.canlet.2021.12.026","article-title":"Sp1-induced lncrna dubr promotes stemness and oxaliplatin resistance of hepatocellular carcinoma via e2f1-cip2a feedback","volume":"528","author":"Liu","year":"2022","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jare.2025.02.016_b0070","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41419-021-04375-3","article-title":"Inhibition of dtymk significantly restrains the growth of hcc and increases sensitivity to oxaliplatin","volume":"12","author":"Sun","year":"2021","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jare.2025.02.016_b0075","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13045-020-00959-2","article-title":"A wee1 family business: Regulation of mitosis, cancer progression, and therapeutic target","volume":"13","author":"Luserna","year":"2020","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jare.2025.02.016_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110261","article-title":"Wee1 kinase protects the stability of stalled DNA replication forks by limiting cdk2 activity","volume":"38","author":"Elb\u00e6k","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.jare.2025.02.016_b0085","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/nsmb.2189","article-title":"Exploiting oncogene-induced replicative stress for the selective killing of myc-driven tumors","volume":"18","author":"Murga","year":"2011","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.jare.2025.02.016_b0090","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2020.09.043","article-title":"Targeting DNA damage response and replication stress in pancreatic cancer","volume":"160","author":"Dreyer","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jare.2025.02.016_b0095","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/s41477-021-00883-4","article-title":"Author correction: A novel wee1 pathway for replication stress responses","volume":"7","author":"Pan","year":"2021","journal-title":"Nat Plants"},{"key":"10.1016\/j.jare.2025.02.016_b0100","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1200\/JCO.20.03167","article-title":"Phase ii study of the wee1 inhibitor adavosertib in recurrent uterine serous carcinoma","volume":"39","author":"Liu","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jare.2025.02.016_b0105","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1158\/1078-0432.CCR-21-0158","article-title":"Adavosertib with chemotherapy in patients with primary platinum-resistant ovarian, fallopian tube, or peritoneal cancer: An open-label, four-arm, phase ii study","volume":"28","author":"Moore","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jare.2025.02.016_b0110","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0140-6736(20)32554-X","article-title":"Adavosertib plus gemcitabine for platinum-resistant or platinum-refractory recurrent ovarian cancer: A double-blind, randomised, placebo-controlled, phase 2 trial","volume":"397","author":"Lheureux","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jare.2025.02.016_b0115","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1158\/1078-0432.CCR-20-3089","article-title":"Clinical efficacy and molecular response correlates of the wee1 inhibitor adavosertib combined with cisplatin in patients with metastatic triple-negative breast cancer","volume":"27","author":"Keenan","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jare.2025.02.016_b0120","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41392-020-00264-x","article-title":"Targeted therapy for hepatocellular carcinoma","volume":"5","author":"Huang","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jare.2025.02.016_b0125","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/jamaoncol.2019.0250","article-title":"Sorafenib plus hepatic arterial infusion of oxaliplatin, fluorouracil, and leucovorin vs sorafenib alone for hepatocellular carcinoma with portal vein invasion: A randomized clinical trial","volume":"5","author":"He","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jare.2025.02.016_b0130","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1080\/14737140.2018.1527688","article-title":"A comprehensive review of protein kinase inhibitors for cancer therapy","volume":"18","author":"Kannaiyan","year":"2018","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.jare.2025.02.016_b0135","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nbt.3437","article-title":"Optimized sgrna design to maximize activity and minimize off-target effects of crispr-cas9","volume":"34","author":"Doench","year":"2016","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jare.2025.02.016_b0140","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1200\/JCO.22.00830","article-title":"Multicenter phase ii trial of the wee1 inhibitor adavosertib in refractory solid tumors harboring ccne1 amplification","volume":"41","author":"Fu","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jare.2025.02.016_b0145","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1172\/JCI122622","article-title":"Inhibiting wee1 and atr kinases produces tumor-selective synthetic lethality and suppresses metastasis","volume":"129","author":"Bukhari","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jare.2025.02.016_b0150","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s13045-022-01360-x","article-title":"The synthetic lethality of targeting cell cycle checkpoints and parps in cancer treatment","volume":"15","author":"Li","year":"2022","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jare.2025.02.016_b0155","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1158\/0008-5472.CAN-18-3631","article-title":"Exploiting DNA replication stress for cancer treatment","volume":"79","author":"Ubhi","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.jare.2025.02.016_b0160","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1158\/0008-5472.CAN-21-4337","article-title":"Asialoglycoprotein receptor 1 functions as a tumor suppressor in liver cancer via inhibition of stat3","volume":"82","author":"Zhu","year":"2022","journal-title":"Cancer Res"},{"key":"10.1016\/j.jare.2025.02.016_b0165","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41388-020-01522-6","article-title":"Eag1 enhances hepatocellular carcinoma proliferation by modulating skp2 and metastasis through pseudopod formation","volume":"40","author":"Chen","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.jare.2025.02.016_b0170","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1200\/JCO.21.01963","article-title":"Arterial chemotherapy of oxaliplatin plus fluorouracil versus sorafenib in advanced hepatocellular carcinoma: A biomolecular exploratory, randomized, phase iii trial (fohaic-1)","volume":"40","author":"Lyu","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jare.2025.02.016_b0175","first-page":"164","article-title":"Culture of patient-derived multicellular clusters in suspended hydrogel capsules for pre-clinical personalized drug screening","volume":"18","author":"Dong","year":"2022","journal-title":"Bioact Mater"},{"key":"10.1016\/j.jare.2025.02.016_b0180","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/cac2.12527","article-title":"Serpine2 promotes liver cancer metastasis by inhibiting c-cbl-mediated egfr ubiquitination and degradation","volume":"44","author":"Zhang","year":"2024","journal-title":"Cancer Commun (Lond)"},{"key":"10.1016\/j.jare.2025.02.016_b0185","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1158\/0008-5472.CAN-23-3594","article-title":"Integrative multiomics analyses identify molecular subtypes of head and neck squamous cell carcinoma with distinct therapeutic vulnerabilities","volume":"84","author":"Diao","year":"2024","journal-title":"Cancer Res"},{"key":"10.1016\/j.jare.2025.02.016_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2020.10.012","article-title":"Metabolic-pathway-based subtyping of triple-negative breast cancer reveals potential therapeutic targets","volume":"33","author":"Gong","year":"2021","journal-title":"Cell Metab"},{"key":"10.1016\/j.jare.2025.02.016_b0195","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s43018-022-00510-x","article-title":"Integrative multi-omics networks identify pkc\u03b4 and DNA-pk as master kinases of glioblastoma subtypes and guide targeted cancer therapy","volume":"4","author":"Migliozzi","year":"2023","journal-title":"Nat Cancer"},{"key":"10.1016\/j.jare.2025.02.016_b0200","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jhep.2023.01.011","article-title":"Identification of a tumour immune barrier in the hcc microenvironment that determines the efficacy of immunotherapy","volume":"78","author":"Liu","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jare.2025.02.016_b0205","doi-asserted-by":"crossref","first-page":"7385","DOI":"10.1158\/0008-5472.CAN-09-1089","article-title":"Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma","volume":"69","author":"Hoshida","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.jare.2025.02.016_b0210","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/hep.21467","article-title":"Transcriptome classification of hcc is related to gene alterations and to new therapeutic targets","volume":"45","author":"Boyault","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jare.2025.02.016_b0215","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25042227","article-title":"DNA double strand break and response fluorescent assays: Choices and interpretation","volume":"25","author":"Atkinson","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jare.2025.02.016_b0220","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/S1470-2045(24)00511-4","article-title":"Comparison of first-line chemotherapy regimens in unresectable locally advanced or metastatic pancreatic cancer: A systematic review and bayesian network meta-analysis","volume":"25","author":"Mastrantoni","year":"2024","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jare.2025.02.016_b0225","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1038\/s41598-023-28486-3","article-title":"Characterization of a novel dual murine model of chemotherapy-induced oral and intestinal mucositis","volume":"13","author":"Mohammed","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jare.2025.02.016_b0230","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0959-8049(96)00497-2","article-title":"Hand-foot syndrome induced by high-dose, short-term, continuous 5-fluorouracil infusion","volume":"33","author":"Chiara","year":"1997","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jare.2025.02.016_b0235","article-title":"Can inhibiting dihydropyrimidine dehydrogenase limit hand-foot syndrome caused by fluoropyrimidines? Clinical Cancer Research : an Official Journal of the American Association For","volume":"14","author":"Yen-Revollo","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.jare.2025.02.016_b0240","article-title":"Platinum prodrug nanoparticles with cox-2 inhibition amplify pyroptosis for enhanced chemotherapy and immune activation of pancreatic cancer","volume":"36","author":"Yu","year":"2024","journal-title":"Adv Mater"},{"key":"10.1016\/j.jare.2025.02.016_b0245","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22158199","article-title":"Targeting DNA damage response and repair to enhance therapeutic index in cisplatin-based cancer treatment","volume":"22","author":"Kiss","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jare.2025.02.016_b0250","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1038\/s41388-022-02274-1","article-title":"Targeting anillin inhibits tumorigenesis and tumor growth in hepatocellular carcinoma via impairing cytokinesis fidelity","volume":"41","author":"Chen","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.jare.2025.02.016_b0255","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the chou-talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123225001146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123225001146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:56:39Z","timestamp":1778835399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123225001146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":51,"alternative-id":["S2090123225001146"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2025.02.016","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive multi-omics analyses expose a precision therapy strategy that targets replication stress in hepatocellular carcinoma using WEE1 inhibition","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2025.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}